The NextGen Clinical Trial Investigator Training is a virtual five-session educational program designed for investigators who currently lead or would like to lead clinical trials. The series includes lectures and panel discussions from leaders across the University of Missouri System, as well as Washington University, to define the regulatory, operational and ethical components of clinical trials, with the goal of developing a skilled workforce that provides the highest level of patient safety, teamwork and data quality. The program also covers institution-specific resources for investigators.

Location: Virtual

Training Timeframe: Five weeks, starting Sept. 11 through Oct. 9

• 5-6:30 p.m. - virtual session program
• Additional videos to view to complete coursework

Sept. 11 - Session 1: Planning for Your Trial
Sept. 18 - Session 2: People and Principles
Sept. 25 - Session 3: Pillars
Oct. 2 - Session 4: Implementation
Oct. 9 - Session 5: Institutional Resources

Register here

Continuing Education

Successful Completion
Successful completion of this activity, which includes participating in the educational offering, participating in the evaluation process, and completing the verification of attendance, enables the learner to satisfy the requirements for continuing education.

Continuing Medical Education
The University of Missouri - Columbia School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Missouri - Columbia School of Medicine, designates this live educational activity for a maximum of 15 AMA PRA Category 1 Credit(s)™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.

American Board of Internal Medicine (ABIM)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 15 Medical Knowledge MOC points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of recognizing participation.

American Board of Pediatrics (ABP)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 15 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.”

Approval Statement
Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Continuing Certification Activities through the ABMS Continuing Certification Directory, NextGen Precision Health Clinical Trial Investigator Training (CTIT)has met the requirements as a Lifelong Learning CME Activity (apply toward general CME requirement) for the following ABMS Member Boards:
NextGen Precision Health Clinical Trial Investigator (CTIT)
Lifelong Learning CME Activity
Psychiatry and Neurology
https://www.continuingcertification.org/activity/nextgen-precision-health-clinical-trial-investigator-ctit-4/

Relevant Financial Relationship Disclosures
Current ACCME (Accreditation Council for Continuing Medical Education) and Midwest Multistate Division, ANCC (American Nurses Credentialing Center’s Commission on Accreditation) rules state that participants in CE activities should be made aware of any relevant affiliation or financial interest in the previous 24 months that may affect the planning of an educational activity or a speaker’s presentation(s). Each planning committee member and speaker has been requested to complete a financial relationship reporting form for the NextGen Precision Health Clinical Trial Investigator Training Series.

• W. David Arnold, MD is a consultant for the following: Dyne, Biohaven, Design Therapeutics, Catalyst Pharmaceuticals, Avidity Biosiences, Insmed, Arthex, Avidity Biosciences, and Arrowhead. Dr. Arnold has also received research grants from Avidity Biosiences.
• Matthew Macaluso, DO has received grant support from the following: Alto, Boehringer-Ingeleheim, Liva Nosa, Janseen, MERCK, Neurocrine, Otsuka, Sage PCORI, & NIMH. Dr. Macaluso is a paid advisor with the following: CME Institute, NuSachi Labs, PharmaTher, Residents Medical, Tactical Mind Solutions, and University of Missouri.
• Suzan Moser, MBA has stock ownership in the following: Johnson & Johnson, Medtronic, Smith & Nephew, and Teleflex (NeoTract).

Clinical Trial Investigator Training is a non-clinical activity.
No other speaker or planning committee member has a relevant financial interest.

Continuing Medical Education Credits for Non-MU Physicians
Physicians on the faculties of the University of Missouri and Washington University in St. Louis may receive Continuing Medical Education credit for CTIT at no cost. Physicians outside of these institutions should contact MU’s Continuing Education for Health Professions. CME will be billed at the prevailing rate of $30/hour. To obtain proof of continuing education credits and to process your payment please send your request to cehp@missouri.edu or call 573-882-4105.